Decision making criteria in oncology

M Glatzer, CM Panje, C Sirén, N Cihoric, PM Putora - Oncology, 2020 - karger.com
Decision making is one of the most complex skills required of an oncologist and is affected
by a broad range of parameters. For example, the wide variety of treatment options, with …

Emotions as social information in shared decision-making in oncology

T Treffers, PM Putora - Oncology, 2020 - karger.com
Emotions play an important role in decision-making and they can impact individual as well
as shared decisions. With increasing complexity of the decision, the potential for emotions to …

[HTML][HTML] International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?

PM Putora, P Leskow, F McDonald… - ERJ open …, 2020 - publications.ersnet.org
Stage III N2 nonsmall cell lung cancer (NSCLC) is a complex disease with poor treatment
outcomes. For patients in whom the disease is considered technically resectable, the main …

Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists

KP Loh, M Abdallah, S Kadambi, M Wells… - Leukemia & …, 2021 - Taylor & Francis
Little is known about the characteristics of patients, physicians, and organizations that
influence treatment decisions in older patients with AML. We conducted qualitative …

Healthcare payer perspectives on the assessment and pricing of oncology multi-indication products: evidence from nine OECD countries

M Mills, P Kanavos - PharmacoEconomics-Open, 2023 - Springer
Background New pharmaceuticals are increasingly being developed for use across multiple
indications. Countries across Europe and North America have adopted a range of different …

Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists

M Glatzer, P Leskow, F Caparrotti… - Translational lung …, 2021 - pmc.ncbi.nlm.nih.gov
Background Stage III N2 non-small cell lung cancer (NSCLC) is a very heterogeneous
disease associated with a poor prognosis. A number of therapeutic options are available for …

Patient autonomy and shared decision‐making in the context of clinical trial participation

F Dennstädt, PM Putora, T Iseli… - European journal of …, 2024 - Wiley Online Library
Aims This study aimed to explore how incorporating shared decision‐making (SDM) can
address recruitment challenges in clinical trials. Specifically, it examines how SDM can align …

Targeting cancer via ribosome biogenesis: the cachexia perspective

VC Figueiredo, JJ McCarthy - Cellular and Molecular Life Sciences, 2021 - Springer
Cancer cachexia afflicts many advanced cancer patients with many progressing to death.
While there have been many advancements in understanding the molecular mechanisms …

Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts

PM Putora, GF Fischer, M Früh, R Califano… - Radiotherapy and …, 2020 - Elsevier
Background Brain metastases (BM) are common in patients with small cell lung cancer
(SCLC). In recent years, the role of whole brain radiotherapy (WBRT) for brain metastases in …

Childhood Cancer-Connect: Identifying solutions to elevating the cancer experience for adolescents and young adults with cancer

ME Roth, DS Hawkins, JK Merrill… - JNCI: Journal of the …, 2025 - academic.oup.com
Adolescents and young adults with cancer (aged 15-39 years) experience unique
challenges because of their developmental life stage, and many have limited access to …